Lexington Biosciences Inc. (LXGTF)

[gopherdat]

Directly above in the corporate presentation it gives the following information.
"Invented and developed over a fifteen year period by Thomas F. Budinger, M.D. Ph.D, and Jonathan S. Maltz, Ph.D, joint-winners of an international award in 2006 for their instrument to assess endothelial function.
Licensed to Lexington by Lawrence Berkeley National Laboratory in the field of cardiovascular vascular health diagnosis and monitoring.
The Lawrence Berkeley National Laboratory (Berkeley Lab) is synonymous with “excellence.”
• Thirteen Nobel Prizes are associated with Berkeley Lab
• Seventy lab scientists are members of the National Academy of Sciences (NAS)
• Thirteen lab scientists have won the National Medal of Science
• Eighteen lab engineers have been elected to the National Academy of Engineering
• Three scientists have been elected into the Institute of Medicine (IOM)"
This wasn't developed by Lexington over a 15 year period.
As for dilution, they have been transparent in that as well in their filings with the Canadian Exchange.
I would not be holding this myself if it were one of the pump & dump excitement generators on the OTC. I see that mostly with the sneaky dilutors. IMO